FoRx Therapeutics

Biotechnology · Health Care

Facts

as of Nov 19, 2026

Next-Generation Therapeutics FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers.

Founded
1986
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Financials

Funding rounds, investors and revenue on record.

$50MTotal raised
Series ALatest round
1Rounds and grants
Money by yearUSD, rounds and grants
2025$50M1 record
Largest rounds and grants
$50M
Sources: funding announcements, grant and company registers

Money

FoRx Therapeutics has $50M paid in by investors, lenders and donors.

$50MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Dec 2025 · Series A
$50MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Milestones

Each milestone is dated by its source: registers, filings, the press